Explore 3 Stock Ideas & Industry Insights Download Free Report

888-969-2592
Shopping Cart 0
countryflagCA
Login

Home CompaniesRadient Technologies Inc

Radient Technologies Inc

Healthcare Drug Manufacturers - Specialty & Generic
PortfolioPortfolio WatchlistWatchlist
Company price
None CAD 0.00(0%)
Last update at 2024-04-09T03:57:51.641912Z
Market Cap
2.70M

Momentum Score

…

Radient Technologies Inc., together with its subsidiaries, processes, manufactures, sells, and distributes cannabis materials in Canada and internationally. It offers vape cartridges or dabs, cannabis oil, standardized cannabinoid ingredients, cannabis extracts, and cannabis formulations. The company also provides extraction services for the extraction, purification, and isolation of cannabinoids for third parties. Its ingredients are used in food and beverage, nutraceuticals, pharmaceuticals, cosmetics, and personal care industries. Radient Technologies Inc. was incorporated in 2001 and is headquartered in Edmonton, Canada.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

52 Week Price Range
0.01
Low
0.01
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High

Key Metrics*

Previous Close
-
Dividend Yield
-
Revenue TTM
3.15M
Revenue Per Share
0.01
Gross Profit TTM
-1.10M
Debt / Equity
-
ROE
-3188.25%
Net Debt
12.02M
ROCE
64.77%
Diluted EPS TTM
-0.02

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-03-31 2021-03-31 2020-03-31 2019-03-31 2018-03-31
Type yearly yearly yearly yearly yearly
Date 2022-03-31 2021-03-31 2020-03-31 2019-03-31 2018-03-31
Income before tax -12.93M -42.27M -37.42M -27.86M -14.05M
Net income -12.93M -42.27M -37.42M -27.86M -14.05M
Selling general administrative 4.74M 10.15M 20.06M 24.12M 12.36M
Gross profit 0.19M -0.50M 0.45M 0.08M 0.19M
Reconciled depreciation 1.71M 2.16M 2.23M 1.13M 0.54M
Ebit -6.45M -21.29M -31.61M -27.88M -13.63M
Ebitda -9.28M -37.51M -34.36M -26.28M -13.31M
Operating income -6.61M -13.87M -25.81M -27.88M -13.63M
Interest expense 1.94M 2.60M 0.83M 0.45M 0.00M
Interest income 0.32M 0.45M 0.23M 0.44M 0.07M
Net interest income -2.36M -2.78M -0.78M -0.22M -0.39M
Income tax expense - - - - 0.00M
Total revenue 3.62M 2.49M 18.40M 0.21M 0.46M
Total operating expenses 10.23M 16.35M 44.22M 28.10M 14.09M
Cost of revenue 3.43M 2.98M 17.96M 0.13M 0.27M
Total other income expense net -3.96M -25.62M -10.82M 0.24M -0.03M
Net income from continuing ops -12.93M -42.27M -37.42M -27.86M -14.05M
Net income applicable to common shares -12.93M -42.27M -37.42M -27.86M -14.05M
Breakdown 2022-03-31 2021-03-31 2020-03-31 2019-03-31 2018-03-31
Type yearly yearly yearly yearly yearly
Date 2022-03-31 2021-03-31 2020-03-31 2019-03-31 2018-03-31
Total assets 27.73M 29.29M 57.93M 61.03M 30.01M
Intangible assets 2.36M 0.60M 0.87M 0.85M 0.08M
Other current assets 0.10M 0.39M 0.45M 0.33M 0.86M
Total liab 37.86M 31.82M 38.92M 10.18M 4.14M
Total stockholder equity -10.13M -2.53M 19.01M 50.84M 25.87M
Other current liab 6.04M 4.72M 8.57M 0.57M 0.20M
Common stock 131.90M 127.13M 112.47M 109.03M 73.28M
Capital stock 131.90M 127.13M 112.47M 109.03M -
Retained earnings -154.10M -146.68M -127.28M -89.87M -62.01M
Other liab - - - 0.01M 0.09M
Other assets 0.15M 0.18M 1.63M 1.01M 0.49M
Cash 0.03M 0.49M 0.15M 31.75M 21.86M
Total current liabilities 37.70M 31.46M 27.88M 3.70M 2.02M
Net debt 12.02M 10.10M 12.90M - -
Short term debt - - - 0.07M 0.22M
Short long term debt 12.05M 10.58M 3.48M 0.07M 0.22M
Property plant equipment 22.63M 25.49M 43.96M 25.34M 4.27M
Total current assets 2.60M 3.02M 11.47M 33.84M 24.05M
Long term investments - - - 0.00M 1.12M
Net tangible assets -12.48M -3.13M 18.14M 50.00M 25.79M
Net receivables 0.14M 0.49M 0.85M 0.20M 0.24M
Long term debt - - 9.57M 6.39M 1.85M
Inventory 2.12M 1.39M 8.89M 0.41M 0.03M
Accounts payable 17.11M 14.61M 14.73M 2.96M 1.50M
Non currrent assets other - 0.00M 0.20M 27.19M 5.97M
Non current assets total 25.14M 26.27M 46.46M 27.19M 5.97M
Capital lease obligations 1.60M 1.32M 1.96M 0.19M 0.29M
Breakdown 2022-03-31 2021-03-31 2020-03-31 2019-03-31 2018-03-31
Type yearly yearly yearly yearly yearly
Date 2022-03-31 2021-03-31 2020-03-31 2019-03-31 2018-03-31
Investments -1.58M -0.01M -11.32M -13.11M -1.68M
Change to liabilities 4.97M 4.66M 8.09M 0.97M 0.34M
Total cashflows from investing activities -1.58M -0.01M -11.32M -13.11M -1.68M
Net borrowings 0.10M -0.48M 6.35M 0.63M -0.31M
Total cash from financing activities 1.30M 7.32M 6.46M 38.33M 23.32M
Change to operating activities 1.35M -2.06M 1.25M 0.44M -1.74M
Net income -12.93M -42.27M -37.42M -27.86M -14.05M
Change in cash -0.45M 0.34M -31.61M 9.90M 13.35M
Begin period cash flow 0.49M 0.15M 31.75M 21.86M 8.51M
End period cash flow 0.03M 0.49M 0.15M 31.75M 21.86M
Total cash from operating activities -0.18M -6.97M -26.75M -15.32M -8.29M
Issuance of capital stock 1.25M 9.63M 0.01M 34.20M -
Depreciation 1.67M 2.11M 2.19M 1.11M 0.54M
Other cashflows from investing activities - 0.09M -0.19M -0.10M -0.36M
Dividends paid 0.00M 0.00M 0.00M 0.00M 0.00M
Change to inventory -0.57M 0.07M -14.20M -0.38M -0.00M
Change to account receivables 0.38M 0.33M -0.65M 0.05M -0.15M
Other cashflows from financing activities -0.05M -1.82M -1.64M -3.06M 1.72M
Change to netincome 4.44M 28.70M 13.80M 10.08M 6.75M
Capital expenditures 1.58M 0.12M 11.07M 12.30M 1.25M
Change in working capital 6.12M 3.00M -5.51M 1.08M -1.56M
Stock based compensation 0.04M 1.57M 2.57M 10.32M -
Other non cash items -0.43M 3.30M 0.63M 0.24M 0.44M
Free cash flow -1.76M -7.09M -37.98M -28.43M -9.62M

Peer Comparison*

Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic

Stock Name
Change
(CAD)
Price
(CAD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
RX
Biosyent Inc.		 0.15
0.87%		 17.30 19.10 15.85 3.96 4.11 3.31 11.03
DB
Decibel Cannabis Company Inc		 -0.04
2.25%		 1.96 - 8.67 0.67 1.20 0.99 17.75
ZYUS
ZYUS Life Sciences Corporation		 -0.03
8.57%		 0.32 - - 108.48 4.41 140.29 -4.26
LSL
LSL Pharma Group Inc.		 -0.01
1.61%		 0.30 20.75 - 1.88 1.89 2.85 10.19

Profile*

Radient Technologies Inc

Radient Technologies Inc., together with its subsidiaries, processes, manufactures, sells, and distributes cannabis materials in Canada and internationally. It offers vape cartridges or dabs, cannabis oil, standardized cannabinoid ingredients, cannabis extracts, and cannabis formulations. The company also provides extraction services for the extraction, purification, and isolation of cannabinoids for third parties. Its ingredients are used in food and beverage, nutraceuticals, pharmaceuticals, cosmetics, and personal care industries. Radient Technologies Inc. was incorporated in 2001 and is headquartered in Edmonton, Canada.

4035 101 Street NW, Edmonton, AB, Canada, T6E 0A4

780 465 1318

https://www.radientinc.com

Name Title Year Born
Dr. Steven Splinter Ph.D. Pres, Interim CEO, Corp. Sec. & Director 1965
Mr. Prakash Hariharan B.Sc., MBA Chief Financial Officer 1972
Mr. Denis M. Taschuk C.A. Advisor 1964
Zachary Riauka Sr. VP of Operations NA
Caitlin Cheadle Director of Communications NA
Dr. David Lafond Ph.D. Managing Director of Global Innovation NA

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Kalkine

3 Mining Stock
Ideas Report

Download a free report with stock ideas and industry insights for general information.

Download Free Report Now → sector image

Top Stocks by Market Cap*

LIF
CAD 21.93
+8.08%
CRON
CAD 5.29
+7.30%
CIA
CAD 2.05
+6.77%
THX
CAD 0.97
+5.43%
OGC
CAD 37.98
+5.38%
GIL
CAD 46.87
-22.45%
IFOS
CAD 1.70
-20.56%
ITH
CAD 1.99
-18.65%
KEEL
CAD 2.41
-17.75%
TNZ
CAD 51.05
-17.39%

Equity Sectors*

  • No sector data available

Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.

Support

Hi! How can we help you today?

Loading…